412 related articles for article (PubMed ID: 30217217)
21. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.
Xiao W; Ma W; Wei S; Li Q; Liu R; Carney RP; Yang K; Lee J; Nyugen A; Yoneda KY; Lam KS; Li T
J Hematol Oncol; 2019 Jun; 12(1):56. PubMed ID: 31182116
[TBL] [Abstract][Full Text] [Related]
22. Exosomes in lung cancer diagnosis and treatment. From the translating research into future clinical practice.
Masaoutis C; Mihailidou C; Tsourouflis G; Theocharis S
Biochimie; 2018 Aug; 151():27-36. PubMed ID: 29857182
[TBL] [Abstract][Full Text] [Related]
23. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
24. Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.
Huang WT; Chong IW; Chen HL; Li CY; Hsieh CC; Kuo HF; Chang CY; Chen YH; Liu YP; Lu CY; Liu YR; Liu PL
Cancer Lett; 2019 Feb; 442():287-298. PubMed ID: 30439539
[TBL] [Abstract][Full Text] [Related]
25. Exosomal proteins as prognostic biomarkers in non-small cell lung cancer.
Sandfeld-Paulsen B; Aggerholm-Pedersen N; Bæk R; Jakobsen KR; Meldgaard P; Folkersen BH; Rasmussen TR; Varming K; Jørgensen MM; Sorensen BS
Mol Oncol; 2016 Dec; 10(10):1595-1602. PubMed ID: 27856179
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
27. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
[TBL] [Abstract][Full Text] [Related]
28. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
29. Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
Lobb RJ; van Amerongen R; Wiegmans A; Ham S; Larsen JE; Möller A
Int J Cancer; 2017 Aug; 141(3):614-620. PubMed ID: 28445609
[TBL] [Abstract][Full Text] [Related]
30. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
31. The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.
Jin H; Wu Y; Tan X
Clin Transl Oncol; 2017 Aug; 19(8):921-930. PubMed ID: 28168600
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.
Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243
[TBL] [Abstract][Full Text] [Related]
33. Power and promise of exosomes as clinical biomarkers and therapeutic vectors for liquid biopsy and cancer control.
Ma YS; Yang XL; Xin R; Liu JB; Fu D
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188497. PubMed ID: 33370570
[TBL] [Abstract][Full Text] [Related]
34. The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment.
Qian Z; Shen Q; Yang X; Qiu Y; Zhang W
Biomed Res Int; 2015; 2015():649161. PubMed ID: 26582468
[TBL] [Abstract][Full Text] [Related]
35. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
Yang XR; Pi C; Yu R; Fan XJ; Peng XX; Zhang XC; Chen ZH; Wu X; Shao Y; Wu YL; Zhou Q
Clin Exp Metastasis; 2021 Feb; 38(1):109-117. PubMed ID: 33231826
[TBL] [Abstract][Full Text] [Related]
36. Potential roles of exosomes in the initiation and metastatic progression of lung cancer.
Liang H; Zhang L; Rong J
Biomed Pharmacother; 2023 Sep; 165():115222. PubMed ID: 37549459
[TBL] [Abstract][Full Text] [Related]
37. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.
Taverna S; Pucci M; Giallombardo M; Di Bella MA; Santarpia M; Reclusa P; Gil-Bazo I; Rolfo C; Alessandro R
Sci Rep; 2017 Jun; 7(1):3170. PubMed ID: 28600504
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Protein Profiling and mRNA Expression of LLC Exosomes.
Zhang W; He P; Wang S; Adili A; Chen Z; Zhang CY; Jiang X; Li J; Zhang Y
Protein J; 2019 Oct; 38(5):586-597. PubMed ID: 31214853
[TBL] [Abstract][Full Text] [Related]
40. Differentially expressed and activated proteins associated with non small cell lung cancer tissues.
Nigro E; Imperlini E; Scudiero O; Monaco ML; Polito R; Mazzarella G; Orrù S; Bianco A; Daniele A
Respir Res; 2015 Jun; 16(1):74. PubMed ID: 26104294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]